Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients
PHASE4CompletedINTERVENTIONAL
Enrollment
66
Participants
Timeline
Start Date
October 31, 2002
Study Completion Date
September 30, 2005
Conditions
Kidney FailureGraft RejectionAged
Interventions
DRUG
Sirolimus
All Listed Sponsors
lead
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
NCT00254709 - Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter